Advertisement
New Treatments Take On Multiple Sclerosis
ResumeOn Monday, the Irish Supreme Court rejected 59-year-old quadriplegic Marie Fleming's plea to be able to end her life with the help of her common-law husband because she can no longer do it herself.
It's a reminder of the horror of multiple sclerosis (MS), a disease of the central nervous system characterized by the progressive degeneration of neurons.
But other patients have different experiences.
Former presidential candidate Mitt Romney's wife Ann Romney, for instance, has lived in remission for years.
We check in on treatment of the disease with Dr. James Bowen, who writes about the latest research in the current issue of Scientific American.
Doctors still don't know what triggers MS and they don't have a cure for it, but new and developing drug therapies have helped many MS patients lead longer lives with less disability.
And Dr. Bowen says about half of his rapidly-degenerating patients who have had bone marrow transplants to treat the disease have seen a reduction in symptom flare-ups.
For some, the disease stabilized for as long as six years.
MS Studies Recommended By Scientific American:
- Multiple Sclerosis: New Insights in Pathogenesis and Novel Therapeutics
- Autologous Hematopoietic Cell Transplantation following High-Dose Immunosuppressive Therapy for Advanced Multiple Sclerosis: Long-Term Results
- Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
- Mesenchymal Stem Cell Transplantation in Multiple Sclerosis
Guest:
- Dr. James Bowen, medical director of the Multiple Sclerosis Center at the Swedish Neuroscience Institute. He's also a clinical associate professor of neurology at the University of Washington.
This segment aired on May 1, 2013.